ClinicalTrials.gov
ClinicalTrials.gov Menu

The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00000654
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : December 18, 2012
Sponsor:
Collaborator:
Oclassen Pharmaceuticals
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : February 1993
Publications:
Tartaglione T, Hooton TM, Jones T, Smiles K, Corey L. Actg 122: phase II tolerance study of oral FIAU in HIV-infected persons. Int Conf AIDS. 1991 Jun 16-21;7(2):254 (abstract no WB2290)